Blog: Depo-Provera

Upcoming JPML Hearing on Depo-Provera Litigation: A Critical Step Toward Consolidation

Jan 21, 2025

In the world of pharmaceutical litigation, a multidistrict litigation (MDL)—as the ongoing Depo Provera lawsuit 2024 is poised to become—is often a critical tool for efficiently managing and consolidating lawsuits involving similar issues or claims. The upcoming hearing by the Judicial Panel on Multidistrict Litigation (JPML) on January 30, 2025, will address the potential formation of an MDL to handle the growing number of lawsuits related to the injectable contraceptive Depo-Provera. Depo-Provera, marketed by Pfizer under...

Warning Signs and Delayed Diagnosis: Navigating Depo-Provera Meningioma Claims

Jan 8, 2025

In a perfect medical system, meningioma would be quickly detected so treatment can begin as soon as possible. However, the frequent delay between initial symptoms and meningioma diagnosis raises significant concerns about the lack of medication warnings impeding patient monitoring. The reality is, many Depo-Provera users experienced symptoms months or even years before receiving proper diagnosis. Studies have shown that extended use of Depo-Provera (medroxyprogesterone acetate) may be associated with the development of meningiomas. While early...

Depo-Provera Meningioma Lawsuits Likely in Australia

Dec 30, 2024

ABC News has reported that Australian women who developed meningioma tumors after Depo-Provera are considering filing a class action against Pfizer. Excerpts: Chanel Stuart-Clarke was just 31 when doctors discovered by accident she had a 15mm brain tumour. The 33-year-old is one of many women globally questioning whether their use of a popular contraceptive called Depo-Provera contributed to the development of their brain tumour. In March, the British Medical Journal (BMJ) published a major study which found women...

Depo-Provera Lawsuits, Meningioma Tumors, and How to File

Dec 2, 2024

Meningiomas are the most common type of brain tumor, accounting for approximately 30% of all brain tumors, according to the Mayo Clinic. Although most meningiomas are benign, their location and growth can cause significant challenges, particularly when they are deemed inoperable. Recent studies have raised concerns about the potential link between prolonged use of Depo-Provera, a popular injectable contraceptive, and an increased risk of developing meningiomas. This revelation has led to Depo Provera lawsuits against pharmaceutical...

Progesterone Contraceptive Depo-Provera Linked to Meningioma Brain Tumors

Nov 27, 2024

Emerging research highlights significant risks associated with prolonged use of certain hormonal contraceptives. Studies now reveal troubling links between progesterone-based contraceptives, such as Depo-Provera, and an increased risk of intracranial meningiomas—serious brain tumors that can cause complications, including vision loss. A recent October 2024 study from the University of Cincinnati, along with pivotal research published earlier in Cancers and The BMJ, underscores the need for greater awareness and accountability regarding long-term injectable contraceptive use. October 2024 Study:...

September Study Links Prolonged Depo-Provera Use to Increased Risk of Brain Tumors

Nov 24, 2024

In September 2024, a significant study published in the journal Cancers revealed a troubling link between the prolonged use of Depo-Provera, an injectable contraceptive containing depot medroxyprogesterone acetate (dMPA), and an increased risk of developing cerebral meningiomas. The large-scale case-control study analyzed over 117,000 meningioma cases and more than one million matched controls using data spanning 2006–2022. It found that “injection exposure” to medroxyprogesterone acetate (Depo-Provera) was associated with a 53% increase in the risk...

How to Sign Up for the Depo-Provera Lawsuit 2024

Nov 23, 2024

If you or a loved one has been diagnosed with meningioma after using Depo-Provera, you may be entitled to pursue legal action. Anapol Weiss, a nationally recognized personal injury law firm, has long been a leader in mass tort claims against some of the largest pharmaceutical companies, including Johnson & Johnson and Pfizer. In October, Anapol Weiss filed the Depo-Provera lawsuit 2024, one of the first complaints specifically alleging that Depo-Provera, manufactured by Pfizer, caused...

A Guide to the History of Depo-Provera

Nov 21, 2024

Depo-Provera, a widely used injectable contraceptive, has a long and complex history of development, medical applications, and controversies. Initially hailed as a breakthrough in birth control, its use has been clouded by numerous studies and global debates about its safety. Recent developments, including a 2024 study linking long-term Depo-Provera use to an increased risk of meningiomas, have raised new questions about its safety. The Discovery of Medroxyprogesterone Acetate Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), was first synthesized...

U.S. News and The Guardian Report: Depo-Provera Associated with an Increased Risk of Tumors

Oct 28, 2024

The excerpts below from The Guardian and U.S. News provide essential information about the French study, announced in March 2024, that found an increased risk of brain and spinal cord tumors to be associated with prolonged Depo-Provera use. The study is referenced in Depo Provera brain tumor lawsuits filed against pharmaceutical manufacturer Pfizer. Anapol Weiss filed its first complaint against Pfizer on October 28, 2024, on behalf of a California woman who used Depo-Provera over...

Depo-Provera Lawsuit Settlements 2024: Most Recent In a Long Line of Litigation Against Unsafe Birth Control Products

Oct 14, 2024

Birth control has been a revolutionary development for women’s reproductive health and autonomy. However, some forms of birth control have also come with serious risks, leading to a wave of lawsuits against manufacturers over the years. From the notorious Dalkon Shield in the 1980s to the more recent Depo-Provera litigation (related to the product’s increased risk of causing brain and spinal cord tumors), the legal landscape surrounding birth control devices and drugs has been fraught...